NN-Labs in the News

On Aug. 7, 2007, NN-Labs was recognized at the roundtable discussion held at U of A at Little Rock entitled “Overcoming Barriers to Nanotechnology Commercialization”.  Robert Cresanti, undersecretary of the U.S. Dept. of Commerce for Technology presented the ‘Recognition of Excellence in Innovation certificate’ to NN-Labs.

A novel, heavy-metal free fluorescent nanocrystal has been developed by NN-Labs in collaboration with the University of Arkansas.  This product line consists of orange and yellow emitting transition metal doped ZnSe quantum dots, D-dotsTM, and is available in polar and non-polar solvents.  Other emission colors will become available in the future.  To learn more and to place orders please visit our products page.

NN-Labs receives two new SBIR awards.  The DOE Phase I award is intended to improve the efficiency of white LEDs for solid state lighting and the EPA Phase I award is for the development of mercury- and cadmium-free alternative lighting sources for general illumination. One of the devices will be based on a pure inorganic structure, while the other uses inorganic-organic composites. The most notable feature of both types of devices will be the incorporation of our new non-toxic nanocrystals, D-dots™.

On February 5, 2007 The National Cancer Institute Alliance for Nanotechnology in Cancer highlighted an article published in the Vol. 7 issue of Nano Letters that covered NN-Labs' and the University of Arkansas' collaborative research on the development of the second generation of quantum dots, transition metal doped zinc selenide or d-dots.

A joint U.S. patent, entitled "Synthesis of Stable Colloidal Nanocrystals using Organic Dendrons," was issued to NN-Labs and the University of Arkansas on December 26, 2006.

Arkansas Venture Forum draws the attention of investors and sparks interest in Arkansas based companies.

NN-Labs was chosen to present at the 5th annual Arkansas Venture Forum held on November 16th and 17th.

October 17, 2006. NN-Labs Receives $2 million in SBIR Contracts for the Research and Development of Nanomaterials for Biomedical Labeling, NN-Labs press release

New Awards

NN-Labs is pleased to announce the award of a Phase I SBIR grant from the NIH on September 1st to develop a nanocrystal-based biosensor, which is capable of simultaneously detecting and quantifying multiple traumatic brain injury (TBI)-specific biomarkers in relatively small volumes of whole blood (0.1-1 uL). The biosensor design utilizes the well-known size dependent photoluminescence (PL) of the semiconductor nanocrystals to label antibodies for the brain injury-specific biomarkers.

Current awards to assess commercialization of nanocrystals.

NIH Phase I SBIR "A Nanocrystal Biosensor for Detection of Multiple TBI Neurochemical Biomarkers" Awarded: September 1, 2007.

DOE Phase I SBIR "Improved Light Extraction Efficiencies of White pc-LEDs for SSL by using Non-Toxic, Non-Scattering, Bright, and Stable Doped ZnSe Quantum Dot Nanophosphors" Awarded: June 20, 2007.

NIH Phase II SBIR "Kits for Converting Nanocrystals to Bio-Reagents" Awarded: September 30, 2006.

NSF Phase II SBIR "Commercial scale production of high quality and affordable Fe₃O₄ nanocrystals for nano-biomedicine" Awarded: August 15, 2006.

Past SBIR awards.

NIH Phase I SBIR "Colloidal Quantum Dot/Well Near-Infrared NanoLabels" Awarded: September 1, 2005.

NIH Phase I SBIR "High Yield and Inexpensive Production of High Quality Gold Nanocrystals for Bio-Labels" Awarded: August 1, 2006.

DOD Phase II SBIR "Highly crystalline semiconductor substrates for high specific power solar cells fabricated by nanocrystal precursors" Awarded: September 1, 2004.

NSF Phase I SBIR "Commercial scale production of high quality and affordable Fe₃O₄ nanocrystals for nano-biomedicine" Awarded: July 1, 2005.

EPA Phase I SBIR "A nanocrystal biosensor array for simultaneous detection of multiple waterborne pathogens" Awarded: March 1, 2005.

NSF Phase II SBIR "Highly efficient, long lifetime, and inexpensive nanocrystal light emitting diodes (LEDs)" Awarded: February 17, 2004.

NIH Phase I SBIR "Kits for converting nanocrystals to standard bio-medical reagents" Awarded: August 4, 2003.

NIH Phase I SBIR "Anti-PSA single chain antibody-quantum dot conjugates" Awarded: March 1, 2004.

NSF Phase II SBIR "A new scale-up technology for industrial production of high quality semiconductor nanocrystals" Awarded: July 31, 2003.

DOD Phase I SBIR "Highly crystalline semiconductor substrates for high specific power solar cells fabricated by nanocrystal precursors" Awarded: July 8, 2003.

NSF Phase I SBIR "Industrial scale formation of the stable and processable core/shell semiconductor nanocrystals" Awarded: December 2002.

NSF Phase I SBIR "Highly efficient, long lifetime, and inexpensive nanocrystal light emitting diodes (LEDs)" Awarded: June 2002.

NSF Phase I SBIR "A new scale-up technology for industrial production of high quality semiconductor nanocrystals" Awarded: June 2002.